{
    "ticker": "VBIVQ",
    "name": "VBI Vaccines Inc.",
    "description": "VBI Vaccines Inc. is a biotechnology company focused on developing and commercializing innovative vaccines to address unmet medical needs. Founded in 2010 and headquartered in Cambridge, Massachusetts, VBI leverages its proprietary enveloped virus-like particle (eVLP) technology platform to create vaccines that are designed to provide enhanced protection against infectious diseases. The company's lead product candidate, an investigational therapeutic vaccine for the treatment of hepatitis B, showcases VBI's commitment to advancing healthcare solutions. VBI is also exploring applications for its technology in oncology and other infectious diseases. With a robust pipeline and a team of experienced scientists and industry veterans, VBI Vaccines aims to transform how vaccines are developed and delivered, ultimately improving patient outcomes. The company places a strong emphasis on research and development, aiming to collaborate with global health organizations to address public health challenges through innovative vaccine solutions. VBI's mission is to create a healthier world through groundbreaking vaccine research and development.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Cambridge, Massachusetts, USA",
    "founded": "2010",
    "website": "https://www.vbivaccines.com",
    "ceo": "Jeffrey Baxter",
    "social_media": {
        "twitter": "https://twitter.com/VBIVaccines",
        "linkedin": "https://www.linkedin.com/company/vbi-vaccines/"
    },
    "investor_relations": "https://investors.vbivaccines.com",
    "key_executives": [
        {
            "name": "Jeffrey Baxter",
            "position": "CEO"
        },
        {
            "name": "David E. Anderson",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Vaccines",
            "products": [
                "VBV-001 (Hepatitis B Vaccine)",
                "VBV-002 (Oncology Vaccine)"
            ]
        }
    ],
    "seo": {
        "meta_title": "VBI Vaccines Inc. | Innovative Vaccine Solutions",
        "meta_description": "Explore VBI Vaccines Inc., a biotechnology company dedicated to developing innovative vaccines for infectious diseases and cancer. Learn about VBI's mission and pipeline.",
        "keywords": [
            "VBI Vaccines",
            "Biotechnology",
            "Vaccines",
            "Hepatitis B",
            "Oncology",
            "Innovative Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What is VBI Vaccines known for?",
            "answer": "VBI Vaccines is known for developing innovative vaccines, particularly targeting infectious diseases and cancer."
        },
        {
            "question": "Who is the CEO of VBI Vaccines?",
            "answer": "Jeffrey Baxter is the CEO of VBI Vaccines Inc."
        },
        {
            "question": "Where is VBI Vaccines headquartered?",
            "answer": "VBI Vaccines is headquartered in Cambridge, Massachusetts, USA."
        },
        {
            "question": "What are VBI's main products?",
            "answer": "VBI's main products include the VBV-001 hepatitis B vaccine and VBV-002 oncology vaccine."
        },
        {
            "question": "When was VBI Vaccines founded?",
            "answer": "VBI Vaccines was founded in 2010."
        }
    ],
    "competitors": [
        "NVAX",
        "MRNA",
        "BNTX"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "GSK",
        "AZN"
    ]
}